{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T14:52:31Z","timestamp":1767192751472,"version":"3.41.0"},"reference-count":34,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.15-266","type":"journal-article","created":{"date-parts":[[2016,4,28]],"date-time":"2016-04-28T16:23:55Z","timestamp":1461860635000},"page":"336-340","source":"Crossref","is-referenced-by-count":11,"title":["No Additional Effect of DPP-4 Inhibitor on Preventing Atrial Fibrosis in Streptozotocin-Induced Diabetic Rat as Compared With Sulfonylurea"],"prefix":"10.1536","volume":"57","author":[{"given":"Noriyuki","family":"Hayami","sequence":"first","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University School of Medicine University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sekiguchi","sequence":"additional","affiliation":[{"name":"The Cardiovascular Institute, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ki","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Murakawa","sequence":"additional","affiliation":[{"name":"Fourth Department of Internal Medicine, Teikyo University School of Medicine University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"The Cardiovascular Institute, Nippon Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Chugh SS, Havmoeller R, Narayanan K, <i>et al<\/i>. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014; 129: 837-47.","DOI":"10.1161\/CIRCULATIONAHA.113.005119"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Brand FN, Abbott RD, Kannel WB, Wolf PA. Characteristics and prognosis of lone atrial fibrillation. 30-year follow-up in the Framingham Study. JAMA 1985; 254: 3449-53.","DOI":"10.1001\/jama.1985.03360240061035"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Go AS, Hylek EM, Phillips KA, <i>et al<\/i>. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-5.","DOI":"10.1001\/jama.285.18.2370"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Benjamin EJ, Wolf PA, D\u2019Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998; 98: 946-52.","DOI":"10.1161\/01.CIR.98.10.946"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Suzuki S, Yamashita T, Ohtsuka T, <i>et al<\/i>. Prevalence and prognosis of patients with atrial fibrillation in Japan: a prospective cohort of Shinken Database 2004. Circ J 2008; 72: 914-20.","DOI":"10.1253\/circj.72.914"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998; 82: 2N-9N.","DOI":"10.1016\/S0002-9149(98)00583-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Krahn AD, Manfreda J, Tate RB, Mathewson FA, Cuddy TE. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995; 98: 476-84.","DOI":"10.1016\/S0002-9343(99)80348-9"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol 2005; 105: 315-8.","DOI":"10.1016\/j.ijcard.2005.02.050"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Ostgren CJ, Merlo J, R\u00e5stam L, Lindblad U. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diabetes Obes Metab 2004; 6: 367-74.","DOI":"10.1111\/j.1462-8902.2004.00358.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Psaty BM, Manolio TA, Kuller LH, <i>et al<\/i>. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997; 96: 2455-61.","DOI":"10.1161\/01.CIR.96.7.2455"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Benjamin EJ, Levy D, Vaziri SM, D\u2019Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994; 271: 840-4.","DOI":"10.1001\/jama.1994.03510350050036"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Pickup JC, Crook MA. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 1998; 41: 1241-8. (Review)","DOI":"10.1007\/s001250051058"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793-801. (Review)","DOI":"10.1172\/JCI29069"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-4.","DOI":"10.1161\/01.CIR.96.4.1180"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Kostin S, Klein G, Szalay Z, Hein S, Bauer EP, Schaper J. Structural correlate of atrial fibrillation in human patients. Cardiovasc Res 2002; 54: 361-79.","DOI":"10.1016\/S0008-6363(02)00273-0"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Yamashita T, Sekiguchi A, Iwasaki YK, <i>et al<\/i>. Recruitment of immune cells across atrial endocardium in human atrial fibrillation. Circ J 2010; 74: 262-70.","DOI":"10.1253\/circj.CJ-09-0644"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dobrian AD, Ma Q, Lindsay JW, <i>et al<\/i>. Dipeptidyl peptidase IV inhibitor sitagliptin reduces local inflammation in adipose tissue and in pancreatic islets of obese mice. Am J Physiol Endocrinol Metab 2011; 300: E410-21.","DOI":"10.1152\/ajpendo.00463.2010"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Omar BA, Vikman J, Winzell MS, <i>et al<\/i>. Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model. Diabetologia 2013; 56: 1752-60.","DOI":"10.1007\/s00125-013-2927-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kirchhof P, Lip GY, Van Gelder IC, <i>et al<\/i>. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork\/European Heart Rhythm Association consensus conference. Europace 2012; 14: 8-27. (Review)","DOI":"10.1093\/europace\/eur241"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Bruins P, te Velthuis H, Yazdanbakhsh AP, <i>et al<\/i>. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997; 96: 3542-8.","DOI":"10.1161\/01.CIR.96.10.3542"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Aviles RJ, Martin DO, Apperson-Hansen C, <i>et al<\/i>. Inflammation as a risk factor for atrial fibrillation. Circulation 2003; 108: 3006-10.","DOI":"10.1161\/01.CIR.0000103131.70301.4F"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 2014; 71: 549-74. (Review)","DOI":"10.1007\/s00018-013-1349-6"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Chung MK, Martin DO, Sprecher D, <i>et al<\/i>. C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-91.","DOI":"10.1161\/hc4901.101760"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005; 95: 764-7.","DOI":"10.1016\/j.amjcard.2004.11.032"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Kato T, Yamashita T, Sekiguchi A, <i>et al<\/i>. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol 2006; 17: 890-4.","DOI":"10.1111\/j.1540-8167.2006.00528.x"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 2001; 50: 537-46. (Review)","DOI":"10.33549\/physiolres.930111"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Goodyear LJ, Hirshman MF, Horton ED, Horton ES. Effect of exercise training and chronic glyburide treatment on glucose homeostasis in diabetic rats. J Appl Physiol 1992; 72: 143-8.","DOI":"10.1152\/jappl.1992.72.1.143"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal 2009; 11: 241-9.","DOI":"10.1089\/ars.2008.2140"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Guo Z, Xia Z, Jiang J, McNeill JH. Downregulation of NADPH oxidase, antioxidant enzymes, and inflammatory markers in the heart of streptozotocin-induced diabetic rats by N-acetyl-L-cysteine. Am J Physiol Heart Circ Physiol 2007; 292: H1728-36.","DOI":"10.1152\/ajpheart.01328.2005"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Van Linthout S, Riad A, Dhayat N, <i>et al<\/i>. Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. Diabetologia 2007; 50: 1977-86.","DOI":"10.1007\/s00125-007-0719-8"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Aron-Wisnewsky J, Tordjman J, Poitou C, <i>et al<\/i>. Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss. J Clin Endocrinol Metab 2009; 94: 4619-23.","DOI":"10.1210\/jc.2009-0925"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Satoh N, Shimatsu A, Himeno A, <i>et al<\/i>. Unbalanced M1\/M2 phenotype of peripheral blood monocytes in obese diabetic patients: effect of pioglitazone. Diabetes Care 2010; 33: e7.","DOI":"10.2337\/dc09-1315"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Leask A. Getting to the heart of the matter: new insights into cardiac fibrosis. Circ Res 2015; 116: 1269-76. (Review)","DOI":"10.1161\/CIRCRESAHA.116.305381"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Sugimoto H, Shikata K, Hirata K, <i>et al<\/i>. Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes 1997; 46: 2075-81.","DOI":"10.2337\/diab.46.12.2075"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/3\/57_15-266\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T22:32:37Z","timestamp":1748903557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/3\/57_15-266\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.15-266","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"type":"print","value":"1349-2365"},{"type":"electronic","value":"1349-3299"}],"subject":[],"published":{"date-parts":[[2016]]}}}